New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-02
DOI
10.1038/s41401-020-00565-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
- (2020) W. Joseph Herring et al. Alzheimers & Dementia
- Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase
- (2020) Jie Wu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ1-42 aggregation
- (2020) Erika Plazas Gonzalez et al. BIOORGANIC CHEMISTRY
- Tacrine-hydroxamate Derivatives as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease: Design, Synthesis, and Biological Evaluation
- (2020) Ana Xu et al. BIOORGANIC CHEMISTRY
- Sodium Oligomannate: First Approval
- (2020) Yahiya Y. Syed DRUGS
- Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta‐Analysis
- (2020) Katrina A.S. Davis et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties
- (2020) Nipun Chopra et al. MOLECULAR PSYCHIATRY
- In search of an anti-inflammatory drug for Alzheimer disease
- (2020) Erika Gyengesi et al. Nature Reviews Neurology
- Suvorexant Ameliorates Cognitive Impairments and Pathology in APP/PS1 Transgenic Mice
- (2020) Fang Zhou et al. NEUROBIOLOGY OF AGING
- The efficacy of statins in the treatment of Alzheimer’s disease: a meta-analysis of randomized controlled trial
- (2020) Kun Xuan et al. NEUROLOGICAL SCIENCES
- An Antisense Oligonucleotide Leads to Suppressed Transcription of Hdac2 and Long-Term Memory Enhancement
- (2020) Shane G. Poplawski et al. Molecular Therapy-Nucleic Acids
- miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease
- (2020) Ana Teresa Barros-Viegas et al. Molecular Therapy-Nucleic Acids
- Discovery of Helminthosporin, an Anthraquinone Isolated from Rumex abyssinicus Jacq as a Dual Cholinesterase Inhibitor
- (2020) Ntemafack Augustin et al. ACS Omega
- Design, synthesis and biological evaluation of 2,3-dihydro-5,6-dimethoxy-1H-inden-1-one and piperazinium salt hybrid derivatives as hAChE and hBuChE enzyme inhibitors
- (2020) Sakineh Mozaffarnia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer’s disease
- (2020) Zhuo Li et al. JOURNAL OF NEUROCHEMISTRY
- Melatonin directly binds and inhibits death‐associated protein kinase 1 function in Alzheimer’s disease
- (2020) Dongmei Chen et al. JOURNAL OF PINEAL RESEARCH
- Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
- (2020) Chong-Su Kim et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer’s Disease
- (2020) Rohith N Thota et al. Nutrients
- Effectiveness and Safety of Acupuncture for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis
- (2020) Yun-Yun Wang et al. Frontiers in Aging Neuroscience
- Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer’s disease: a meta-analytic review on potential mechanisms
- (2020) Chuan Qin et al. Translational Neurodegeneration
- Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors
- (2020) Jie Wang et al. World Journal of Stem Cells
- A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice
- (2020) Júlia Companys-Alemany et al. Pharmaceutics
- Intranasal delivery of mesenchymal stem cell secretome repairs the brain of Alzheimer’s mice
- (2020) Giulia Santamaria et al. CELL DEATH AND DIFFERENTIATION
- Brain‐targeted co‐delivery of β‐amyloid converting enzyme 1 shRNA and epigallocatechin‐3‐gallate by multifunctional nanocarriers for Alzheimer's disease treatment
- (2020) Lijie Lv et al. IUBMB LIFE
- miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1
- (2020) Pengxiang Li et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress
- (2020) Radoslaw Magierski et al. Frontiers in Pharmacology
- Exercise benefits on Alzheimer’s disease: State-of-the-science
- (2020) Pedro L. Valenzuela et al. AGEING RESEARCH REVIEWS
- Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®
- (2019) Nagaendran Kandiah et al. CNS Neuroscience & Therapeutics
- The Role of NMDA Receptors in Alzheimer’s Disease
- (2019) Jinping Liu et al. Frontiers in Neuroscience
- Alteration in sleep architecture and electroencephalogram as an early sign of Alzheimer's disease preceding the disease pathology and cognitive decline
- (2019) Feng Zhang et al. Alzheimers & Dementia
- Pharmacokinetics, bioavailability and tissue distribution study of JCC-02, a novel N-methyl-d-aspartate (NMDA) receptor inhibitor, in rats by LC-MS/MS
- (2019) Tian Yang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Alzheimer disease and aducanumab: adjusting our approach
- (2019) Dennis J. Selkoe Nature Reviews Neurology
- Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
- (2019) David Henley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Target Engagement in an Alzheimer Trial: Crenezumab Lowers Aβ Oligomers in CSF
- (2019) Ting Yang et al. ANNALS OF NEUROLOGY
- Simvastatin Efficiently Reduces Levels of Alzheimer’s Amyloid Beta in Yeast
- (2019) Sudip Dhakal et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Models for skin and brain penetration of major components from essential oils used in aromatherapy for dementia patients
- (2019) Snezana Agatonovic-Kustrin et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
- (2019) Adam L Boxer et al. LANCET NEUROLOGY
- Management of Behavioral and Psychological Symptoms of Dementia
- (2019) Laurel J. Bessey et al. Current Psychiatry Reports
- MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents?
- (2019) Francesco Angelucci et al. Frontiers in Pharmacology
- Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
- (2019) Xinyi Wang et al. CELL RESEARCH
- Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease
- (2019) Yanan Liu et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Statin Use and Risk of Cognitive Decline in the ADNI Cohort
- (2019) Emily C. Kemp et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
- (2019) Alette M. Wessels et al. JAMA Neurology
- Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease
- (2019) Robert Howard et al. JAMA Neurology
- Intranasal Administration of miR-146a Agomir Rescued the Pathological Process and Cognitive Impairment in an AD Mouse Model
- (2019) Hui Mai et al. Molecular Therapy-Nucleic Acids
- BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology
- (2018) Finn Peters et al. ACTA NEUROPATHOLOGICA
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- The role of 5 HT6-receptor antagonists in Alzheimer’s disease: an update
- (2018) Rita Khoury et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease
- (2018) Alireza Atri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores
- (2018) Jagadish K. Chhetri et al. JOURNAL OF ALZHEIMERS DISEASE
- Guanfacine treatment for prefrontal cognitive dysfunction in older participants: a randomized clinical trial
- (2018) Nicole M. Barcelos et al. NEUROBIOLOGY OF AGING
- Rhynchophylline suppresses soluble Aβ 1-42 -induced impairment of spatial cognition function via inhibiting excessive activation of extrasynaptic NR2B-containing NMDA receptors
- (2018) Yang Yang et al. NEUROPHARMACOLOGY
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil
- (2018) Terence Fullerton et al. Alzheimers Research & Therapy
- Impacts of Acute Hypoxia on Alzheimer's Disease-Like Pathologies in APPswe/PS1dE9 Mice and Their Wild Type Littermates
- (2018) Feng Zhang et al. Frontiers in Neuroscience
- A Novel Tetramethylpyrazine Derivative Prophylactically Protects against Glutamate-Induced Excitotoxicity in Primary Neurons through the Blockage of N-Methyl-D-aspartate Receptor
- (2018) Shengquan Hu et al. Frontiers in Pharmacology
- Improvement of Main Cognitive Functions in Patients with Alzheimer’s Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study
- (2018) José Enrique de la Rubia Ortí et al. JOURNAL OF ALZHEIMERS DISEASE
- Pathological Impacts of Chronic Hypoxia on Alzheimer’s Disease
- (2018) Feng Zhang et al. ACS Chemical Neuroscience
- Ginkgolide A Prevents the Amyloid-β-Induced Depolarization of Cortical Neurons
- (2018) Li-Chen Kuo et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
- (2018) Petr Novak et al. Alzheimers Research & Therapy
- The missing link between sleep disorders and age-related dementia: recent evidence and plausible mechanisms
- (2017) Feng Zhang et al. JOURNAL OF NEURAL TRANSMISSION
- Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial
- (2017) Sandrine Andrieu et al. LANCET NEUROLOGY
- Comparative effect of statins on the risk of incident Alzheimer disease
- (2017) Liliya Sinyavskaya et al. NEUROLOGY
- ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease
- (2017) Courtney Lane-Donovan et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Acute Hypoxia Induced an Imbalanced M1/M2 Activation of Microglia through NF-κB Signaling in Alzheimer’s Disease Mice and Wild-Type Littermates
- (2017) Feng Zhang et al. Frontiers in Aging Neuroscience
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- AVP-786 for the treatment of agitation in dementia of the Alzheimer’s type
- (2016) Ricardo P. Garay et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer’s Disease-Like Pathologies in AβPPswe/PS1ΔE9 Mice
- (2016) Hongyan Qiu et al. JOURNAL OF ALZHEIMERS DISEASE
- Complications and safety of vagus nerve stimulation: 25 years of experience at a single center
- (2016) David Révész et al. Journal of Neurosurgery-Pediatrics
- Effects of Exercise on Cognition: The Finnish Alzheimer Disease Exercise Trial: A Randomized, Controlled Trial
- (2016) Hannareeta Öhman et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer’s disease: a randomized, placebo-controlled trial
- (2016) Martin Bystad et al. Alzheimers Research & Therapy
- Human gut microbiota: the links with dementia development
- (2016) Rashad Alkasir et al. Protein & Cell
- Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies
- (2016) Isaac G. Onyango et al. Aging and Disease
- Efficacy of musical interventions in dementia: methodological requirements of nonpharmacological trials
- (2015) Séverine Samson et al. Annals of the New York Academy of Sciences
- Role of RAGE in Alzheimer’s Disease
- (2015) Zhiyou Cai et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Therapeutic targeting of autophagy in neurodegenerative and infectious diseases
- (2015) David C. Rubinsztein et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration
- (2015) Karsten Ruscher et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory
- (2015) Oliver Stiedl et al. Frontiers in Pharmacology
- Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease
- (2014) Dietmar Rudolf Thal et al. ACTA NEUROPATHOLOGICA
- Dual roles for autophagy: Degradation and secretion of Alzheimer's disease Aβ peptide
- (2014) Per Nilsson et al. BIOESSAYS
- The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia
- (2014) Mariagiovanna Cantone et al. CLINICAL NEUROPHYSIOLOGY
- Promoting Autophagic Clearance: Viable Therapeutic Targets in Alzheimer’s Disease
- (2014) Lauren G. Friedman et al. Neurotherapeutics
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preventive Effects of Ramelteon on Delirium
- (2014) Kotaro Hatta et al. JAMA Psychiatry
- Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease
- (2013) Jing-ying Jia et al. ACTA PHARMACOLOGICA SINICA
- Alzheimer disease therapy—moving from amyloid-β to tau
- (2013) Ezio Giacobini et al. Nature Reviews Neurology
- Tau degradation: The ubiquitin–proteasome system versus the autophagy-lysosome system
- (2013) Min Jae Lee et al. PROGRESS IN NEUROBIOLOGY
- Cognitive training and cognitive rehabilitation for persons with mild to moderate dementia of the Alzheimer's or vascular type: a review
- (2013) Alex Bahar-Fuchs et al. Alzheimers Research & Therapy
- Transcranial brain stimulation studies of episodic memory in young adults, elderly adults and individuals with memory dysfunction: A review
- (2012) Rosa Manenti et al. Brain Stimulation
- A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease
- (2012) Donald E. Moss et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- Functional Alterations in Memory Networks in Early Alzheimer’s Disease
- (2010) Reisa A. Sperling et al. NEUROMOLECULAR MEDICINE
- Alzheimer's disease: brain expression of a metabolic disorder?
- (2010) Sara Merlo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Memory enhancement induced by hypothalamic/fornix deep brain stimulation
- (2008) Clement Hamani et al. ANNALS OF NEUROLOGY
- Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities
- (2008) Rixt F. Riemersma-van der Lek JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation